Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study

ConclusionIFN- β1a evening injections in the first 8 weeks of treatment led to an improvement in FLS; when continuing therapy, time of administration could be decided according to patient’s lifestyle and preference.

http://link.springer.com/10.1007/s00415-020-09771-x

Source: Journal of Neurology - March 4, 2020 Category: Neurology Source Type: research